Compounds represented by the general formula (1):
[wherein R1 is typically an aminoalkyl group; R2 is typically a hydrogen atom, a lower alkyl group, R3 or SR4 (where R4 is typically a lower alkyl group); Ar is typically a 5-membered aromatic heterocyclic group] have an NOS inhibiting activity and are useful as therapeutics of cerebrovascular diseases and other pharmaceuticals.
一般式(1)所代表的化合物:[其中R1通常是
氨基烷基;R2通常是氢原子,低碳基,R3或SR4(其中R4通常是低碳基);Ar通常是5-成员芳香杂环基]具有NOS抑制活性,并可用作治疗脑血管疾病和其他药物的治疗剂。